Strategic Acquisition Camargo has recently integrated into Premier Research through acquisition, signaling a broader global platform and extended capabilities. This presents cross-sell opportunities for end-to-end development, regulatory, and commercial services across larger sponsor organizations.

Global Reach With clients in more than 35 countries, Camargo offers multi-regional expertise that can help sponsors navigate complex regulatory landscapes and accelerate global development programs, suggesting opportunities for international programs and cross-border studies.

Specialty Focus Expertise in rare and accelerated approval pathways, orphan drugs, 505(b)(2), oncology, neurology, pediatrics, combination products, and digital therapeutics indicates a strong selling point for sponsors pursuing complex or innovative modalities requiring specialized regulatory and development support.

Recent Growth Active expansion activities and prior acquisitions (Paidion Research, InSymbiosis) demonstrate a growth trajectory and integration capability that can be leveraged to offer expanded services, capacity for larger programs, and quick-onboarding of new therapeutic areas.

Mid-Market Advantage Size and revenue range position Camargo as a compelling partner for emerging to mid-size biopharma seeking scalable, integrated development solutions without the heft of larger CROs, presenting an opportunity to target growing sponsors looking for capital efficiency and speed to milestones.